Exterro Launches Industry’s First Autonomous AI Engine to Eliminate Up to 95% of manual Subpoena Work and Reclaim 7,500 Enterprise Hours 
CleverTap and Rabbit Rewards win Silver at Thailand MarTech Awards 2026 for real-time, agentic customer engagement 
Gold Peak completes a HK$675 million Green and Sustainability Linked Term Loan Facility Interim Results for the Six Months ended 30 June 2021 – Barhemsys® and Byfavo® Launches Continue to Achieve Strong Hospital Formulary Adoption
This announcement contains inside information for the purposes of Article 7 of the Market Abuse…
OXURION Announces Positive Results from Part A of Phase 2 Study Evaluating THR-149 for Treatment of Diabetic Macular Edema (DME)
Decision taken to move the highest dose of THR-149 (0.13mg) into Part B of the…
ObsEva Announces Appointment of Luigi Marro as Chief Transformation Officer
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA,…
Hangzhou Chance Pharmaceuticals Appoints Guobao Zhao as Senior Vice President
HANGZHOU, China, Sept. 30, 2021 (GLOBE NEWSWIRE) — Hangzhou Chance Pharmaceuticals (“Chance”), a clinical-stage biotechnology…
Tower One Wireless Enters a New Debt Financing Arrangement for US$25,000,000 With Itaú Corpbanca Colombia S.A. and a Local Partner
VANCOUVER, British Columbia, Sept. 29, 2021 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (CSE: TO)…
Altimmune to Host Key Opinion Leader Call with Dr. Stephen Harrison on Pemvidutide Phase 1 Clinical Trial Results on September 30, 2021
GAITHERSBURG, Md., Sept. 29, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
SeqLL Inc. Announces Closing of Underwriters’ Option to Purchase Additional Shares of Common Stock in Connection with its Initial Public Offering
WOBURN, Mass., Sept. 29, 2021 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:SQL;…
CENTOGENE’s Ground-Breaking Family Genetic Research Published in the New England Journal of Medicine Reveals Path to Potential Cure for Structural Birth Defects
Collaborative research utilized insights gained from CENTOGENE’s rare disease-centric Bio/Databank to help analyze data of…
Skye Bioscience Announces Closing of $7.0 Million Registered Direct Offering
SAN DIEGO, CA, Sept. 29, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE”…
Coherus BioSciences Mourns the Passing of Board Member Dr. Samuel Nussbaum
REDWOOD CITY, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) — It is with profound sadness that…
GENFIT Reports First Half-Year 2021 Financial Results and Provides Corporate Update
GENFIT Reports First Half-Year 2021 Financial Results and Provides Corporate Update Financial highlights Cash and…
Ascendis Pharma A/S Announces Share Repurchase Program
COPENHAGEN, Denmark, Sept. 29, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
Mountain Valley MD Holdings Provides Business Update, Results of Shareholder Meeting
TORONTO, Sept. 29, 2021 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
4D Molecular Therapeutics to Participate in Chardan’s 5th Annual Genetic Medicines Conference
EMERYVILLE, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT), a clinical-stage…
BioCorRx to Present at LD Micro Main Event on Tuesday, October 12th
ANAHEIM, CA, Sept. 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”),…
Agenda and draft decisions of the extraordinary shareholders’ meeting of joint stock company “Olainfarm”
Management board of the joint stock company “Olainfarm”, registration No 40003007246, registered address: Rūpnīcu iela…
Guerbet: Guerbet contributes to the NH TherAguix IPO on Euronext Growth, a specialist in innovative biotechnologies for precision radiotherapy
Guerbet contributes to the NH TherAguix IPO on Euronext Growth, a specialist in innovative biotechnologies…
PharmaTher Retains Former FDA Psychiatry Division Director Dr. Thomas Laughren as Regulatory Affairs Advisor
TORONTO, Sept. 29, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB:…
PAOG CBD Nutraceutical Launch Timed To Capture Market Momentum
Sandusky, OH, Sept. 29, 2021 (GLOBE NEWSWIRE) — PAO Group, Inc. (OTC Pink: PAOG) has…
The Consortium for Top-Down Proteomics Launches a New Initiative to Develop the Human Proteoform Atlas
The project will engage the community to build the definitive reference set of the human…